Chemveda

San Diego, United States Founded: 2010 • Age: 16 yrs
Contract research and manufacturing services for small molecules are provided.

About Chemveda

Chemveda is a Healthcare company based in San Diego (United States) founded in 2010. Contract research and manufacturing services for small molecules are provided. Chemveda has raised $2.58 million across 3 funding rounds from investors including United States Department of Agriculture, Rajesh Vankayalapati and Ravi Kumar Puthukanoori. The company has 498 employees. Its Indian entity Chemveda Life Sciences India Private Limited reported revenue of β‚Ή116 Cr. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry.

Company details

Chemveda was founded in 2010 and is based in San Diego, United States. Operations focus on the pharmaceutical sector, where contract research and development services are delivered for small molecules. Key offerings include medicinal chemistry, custom synthesis, process chemistry, pre-formulation and formulation support, pegylation, medical writing, and clinical research. Collaborative drug development services are also extended through the domain chemvedals.com.

Key Metrics
  • Indian entity revenue
    ₹116 Cr

    FY 2024 · +14% YoY

  • Indian entity net profit
    ₹18.56 Cr

    FY 2024 · 16% margin

  • Indian entity EBITDA
    ₹31.48 Cr

    FY 2024 · 27% margin

  • Total Equity Funding
    $2.58M (USD)

    in 3 rounds

  • Latest Funding Round
    $1.13M (USD), Seed

    May 2022

  • Investors
  • Employee Count
    498

Apps and channels of Chemveda

its YouTube channel Chemveda Life Sciences has 21 subscribers and 1 videos.

Chemveda Life Sciences
YouTube 21 subscribers 1 videos Science & Technology
Open channel

Videos from Chemveda

The most watched videos on Chemveda's YouTube channel, Chemveda Life Sciences (21 subscribers). Click a video to play it here.

Chemveda & Q BioMed, Inc. Announce Potential Chemotherapeutic Breakthrough in Liver Cancer
272 views

More on Chemveda Life Sciences.

Funding Insights of Chemveda

Chemveda has successfully raised a total of $2.58M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.13 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.58M
  • Total Rounds 3
  • Last Round Seed β€” $1.13M
  • First Round $196,000

    (Sep 2009)

  • Investors Count 7

All 3 funding rounds of Chemveda with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2022$1.13MSeed–Rajesh Vankayalapati, Pasidi Greenlands
Nov 2021$1.45MSeed–Hithaishi Paraselli, Athulith Paraselli
–
Sep 2009$196,000Grant––
Valuation history

7 investors in total: 2 institutional and 5 angel.

Investors in Chemveda

Chemveda has secured backing from 7 investors, including angel and institutional investors. Prominent investors backing the company include United States Department of Agriculture, Rajesh Vankayalapati and Ravi Kumar Puthukanoori.

All
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Food products are processed by Pasidi Greenlands in India.
pasidigreenlands.tcc.modeHyderabad, India
Leadership is provided on agriculture, food, and rural development matters.
1862usda.gov

Rajesh Vankayalapati

unknown_5f93bb1f74414d60a

Ravi Kumar Puthukanoori

unknown_d0bba7025a9045c99

Bharathi Gorrepati

unknown_413e303edda44d2bb

Hithaishi Paraselli

unknown_c4a35e7c5ff34d71a

Athulith Paraselli

unknown_c1c599c1d6f64ac6b
Premium access

Investor details for Chemveda

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Chemveda Life Sciences India Private Limited (Chemveda)

Chemveda Life Sciences India Private Limited is the primary company behind Chemveda. The board of Chemveda Life Sciences India Private Limited currently have 4 directors; the longest-serving is Paraselli Bheemarao, appointed in 2012. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Paraselli Bheemarao
DIN 02483052
Director03 Dec 201213 yrs 10 moChemveda Life Sciences India Private Limited
Guntupalli Pratyusha
DIN 06390402
Director14 Apr 201610 yrs 6 moChemveda Life Sciences India Private Limited
Veera Venkata Rama Rao Remella
DIN 06998628
Director02 Dec 20205 yrs 10 moChemveda Life Sciences India Private Limited
Hithaishi Paraselli
DIN 10859625
Additional Director11 Dec 20241 yr 10 moChemveda Life Sciences India Private Limited

People of Chemveda

35 people are tracked at Chemveda (10 in leadership, 25 in team); the tracked headcount is 498.

NameRoleGroup
Dr. Sampath K Nangunoori
Associate Vice President CCSLeadership
Siva Kumar Susarla
Director And HOD -analyticalLeadership
Pankajkumar Singh
DirectorLeadership
Piyush Chahar
Director & Head, Global Business DevelopmentLeadership
Ravi Kumar Puthukanoori
Vice President-discovery And Development ServicesLeadership
Dr. Bheema Paraselli
CEO, PresidentLeadership
Shambabu Joseph
Vice PresidentLeadership
Vesa Nevalainen
Vice President, Business Development, Sales And MarketingLeadership
Ramana Murthy V Appala
Associate DirectorLeadership
Brahmaiah Dabbugoddu
Associate DirectorLeadership
Venkatesh Vavilapalli
Business Development ExecutiveTeam
Muhammad Abdul Qavi
Senior Research AnalystTeam
Vijay Reddy
Principal ScientistTeam
Dr. Rudrakanta Satapathy
Principal ScientistTeam
Kalyan Sagar
HR ManagerTeam
Dr. Devendram Vangoor
Senior Research ScientistTeam
Dr. Karthik Sekar
Senior ScientistTeam
Shabari Prasad Suggala
Senior Research ScientistTeam
Dr. Thirupathi Gogula
Associate Principal ScientistTeam
Dr Ravinder Mettu
Principal ScientistTeam

15 more people are available in the full profile.

Premium access

Complete people profiles for Chemveda

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Chemveda

Figures of Chemveda Life Sciences India Private Limited, the primary company behind Chemveda, for FY 2024. Revenue was ₹116 Cr (+14% year on year). Net profit was ₹18.56 Cr (16% margin). EBITDA was ₹31.48 Cr (27% margin). Revenue has grown at a compounded annual rate of +38% over three years and +38% over five years.

  • ₹116 CrRevenue · FY 2024 · +14% YoY
  • ₹18.56 CrNet profit · 16% margin
  • ₹31.48 CrEBITDA · 27% margin
  • ₹16.15 CrPaid-up capital
  • 498Employees (provident fund records)
  • +38%Revenue CAGR, 3 years
  • +38%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Chemveda Life Sciences India Private Limited are on its company page.

Premium access

Detailed financial statements for Chemveda

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Chemveda

3 dated milestones of Chemveda across 13 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $196K.
  2. Founded Chemveda is founded.
  3. Funding Latest funding round, Seed, of $1.1M.

Web traffic of Chemveda

The website of Chemveda (chemvedals.com) receives about 1.8K visits a month.

  • Monthly visits
    1.8K
Similar websites

Websites whose visitors overlap most with Chemveda. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
manvibiopharma.com
100%
View details
ji-techindia.co.in
100%
View details
rolonseals.com
rolonseals.com
99%
#10,092,525–
avrasynthesis.com
98%
View details
sicgil.com
98%
#11,736,047View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Chemveda

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Chemveda (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Chemveda

Premium access

Complete news archive for Chemveda

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chemveda

Chemveda was founded in 2010.

Chemveda is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Chemveda is a funded company, having raised a total of $2.58M across 3 funding rounds to date. The company's 1st funding round was a Grant of $196K, raised on Sep 2009.

Chemveda has 498 employees.

The primary company behind Chemveda, Chemveda Life Sciences India Private Limited, reported revenue of β‚Ή116 Cr for FY 2024, up 14% year on year.

Chemveda was founded in 2010 and is based in San Diego, United States. Operations focus on the pharmaceutical sector, where contract research and development services are delivered for small molecules. Key offerings include medicinal chemistry, custom synthesis, process chemistry, pre-formulation and formulation support, pegylation, medical writing, and clinical research. Collaborative drug development services are also extended through the domain chemvedals.com.

Chemveda has 7 investors. Key investors include United States Department of Agriculture, Rajesh Vankayalapati, Ravi Kumar Puthukanoori, Bharathi Gorrepati, and Pasidi Greenlands.

Chemveda operates through Chemveda Life Sciences India Private Limited.

The legal entities of Chemveda currently have 5 directors, including Paraselli Bheemarao, Nidhi Khandelwal, Guntupalli Pratyusha and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available